World PulseNow
Newsletter

Novo Nordisk to Buy Blood Disease Drug From Omeros for Up to $2.1 Billion

Dow Jones – Health•Wednesday, October 15, 2025 at 3:25:00 PM
PositiveHealth
Novo Nordisk to Buy Blood Disease Drug From Omeros for Up to $2.1 Billion
Novo Nordisk's recent agreement to acquire the blood disease drug zaltenibart from Omeros for up to $2.1 billion marks a significant step in expanding its portfolio. This deal not only highlights Novo Nordisk's commitment to addressing critical health issues but also positions them to potentially lead in the treatment of blood diseases. The exclusive global rights to develop and commercialize zaltenibart could pave the way for innovative therapies, benefiting patients and enhancing the company's market presence.
— Curated by the World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Latest from Health
Trump Rattles Vaccine Experts Over Aluminum
The New York Times3 hours ago
Trump Rattles Vaccine Experts Over Aluminum
NegativeHealth
Former President Donald Trump has stirred controversy by questioning the safety of aluminum in vaccines, raising concerns among health experts. His remarks could undermine public trust in vaccination efforts, especially as the nation continues to combat various diseases. This is significant because it highlights the ongoing debate around vaccine safety and the influence of political figures on public health perceptions.
Read full article
via The New York Times
Democratic governors form a public health alliance in a rebuke of Trump
NPR4 hours ago
Democratic governors form a public health alliance in a rebuke of Trump
PositiveHealth
A coalition of Democratic governors has come together to form a public health alliance, aiming to enhance data sharing and communication regarding health threats and emergency preparedness. This initiative is particularly significant as it arises during a period when many feel the federal government is falling short in its public health responsibilities. By collaborating, these governors hope to ensure better health outcomes for their states and address pressing health issues more effectively.
Read full article
via NPR
No evidence Canadian schools banning pork from lunches as rumours spread
Global News6 hours ago
No evidence Canadian schools banning pork from lunches as rumours spread
NegativeHealth
Recent rumors have circulated on TikTok suggesting that schools in Ontario and Alberta are banning pork from lunchboxes due to concerns about offending religious students. However, there is no evidence to support these claims, and officials have not confirmed any such policies. This misinformation highlights the challenges schools face in addressing dietary needs while fostering an inclusive environment. It's important for parents to verify information before reacting to such claims.
Read full article
via Global News
America Is Heavily Reliant on China for Raw Materials in Medicines
The New York Times6 hours ago
America Is Heavily Reliant on China for Raw Materials in Medicines
NegativeHealth
America's heavy reliance on China for raw materials in medicines raises significant concerns about national security and public health. As the U.S. grapples with supply chain vulnerabilities, this dependency could lead to shortages and increased costs for essential medications. Understanding this issue is crucial as it highlights the need for diversification in sourcing and the potential risks associated with over-reliance on a single country.
Read full article
via The New York Times
Novo Nordisk to Buy Blood Disease Drug From Omeros for Up to $2.1 Billion
Dow Jones – Health7 hours ago
Novo Nordisk to Buy Blood Disease Drug From Omeros for Up to $2.1 Billion
PositiveHealth
Novo Nordisk's recent agreement to acquire the blood disease drug zaltenibart from Omeros for up to $2.1 billion marks a significant step in expanding its portfolio. This deal not only highlights Novo Nordisk's commitment to addressing critical health issues but also positions them to potentially lead in the treatment of blood diseases. The exclusive global rights to develop and commercialize zaltenibart could pave the way for innovative therapies, benefiting patients and enhancing the company's market presence.
Read full article
via Dow Jones – Health
How to Understand and Manage Perimenopause Symptoms
NBC News8 hours ago
How to Understand and Manage Perimenopause Symptoms
PositiveHealth
Dr. Heather Hirsch, a board-certified internist, is shedding light on perimenopause in her new book, 'The Perimenopause Survival Guide.' In her recent appearance on TODAY, she discusses how to identify symptoms and find relief, making this information crucial for many women navigating this phase of life. Understanding perimenopause can empower women to manage their health better and improve their quality of life.
Read full article
via NBC News